MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months.
Edward Tieng Chek ChokeTjun Yip TangEilane PehKarthikeyan DamodharanShin Chuen ChengJia Sheng TayAloke V FinnPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)
MagicTouch PTA SCB in the XTOSI study showed promising 6-month primary patency and encouraging 12-month freedom from CD-TLR, AFS, and limb salvage rates. No early safety concerns were raised. Randomized trials are needed to investigate the safety and efficacy of SCB for treatment of PAOD.